597 related articles for article (PubMed ID: 26518171)
1. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.
Gill L; Zarbo A; Isedeh P; Jacobsen G; Lim HW; Hamzavi I
J Am Acad Dermatol; 2016 Feb; 74(2):295-302. PubMed ID: 26518171
[TBL] [Abstract][Full Text] [Related]
2. Comorbidities in vitiligo: comprehensive review.
Dahir AM; Thomsen SF
Int J Dermatol; 2018 Oct; 57(10):1157-1164. PubMed ID: 29808541
[TBL] [Abstract][Full Text] [Related]
3. Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis.
Lee JH; Ju HJ; Seo JM; Almurayshid A; Kim GM; Ezzedine K; Bae JM
J Invest Dermatol; 2023 May; 143(5):777-789.e6. PubMed ID: 36574529
[TBL] [Abstract][Full Text] [Related]
4. Comorbidities associated with vitiligo: a ten-year retrospective study.
Sheth VM; Guo Y; Qureshi AA
Dermatology; 2013; 227(4):311-5. PubMed ID: 24107643
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.
Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261
[TBL] [Abstract][Full Text] [Related]
6. Comorbid autoimmune diseases in patients with pemphigus: a nationwide case-control study in Taiwan.
Chiu YW; Chen YD; Hua TC; Wu CH; Liu HN; Chang YT
Eur J Dermatol; 2017 Aug; 27(4):375-381. PubMed ID: 28747284
[TBL] [Abstract][Full Text] [Related]
7. Quality of Life, Burden of Disease, Co-morbidities, and Systemic Effects in Vitiligo Patients.
Elbuluk N; Ezzedine K
Dermatol Clin; 2017 Apr; 35(2):117-128. PubMed ID: 28317521
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study.
Chu SY; Chen YJ; Tseng WC; Lin MW; Chen TJ; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
J Am Acad Dermatol; 2011 Nov; 65(5):949-56. PubMed ID: 21616562
[TBL] [Abstract][Full Text] [Related]
9. Associations of chronic urticaria with atopic and autoimmune comorbidities: a nationwide population-based study.
Chiu HY; Muo CH; Sung FC
Int J Dermatol; 2018 Jul; 57(7):822-829. PubMed ID: 29663342
[TBL] [Abstract][Full Text] [Related]
10. Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study.
de Lusignan S; Alexander H; Broderick C; Dennis J; McGovern A; Feeney C; Flohr C
J Allergy Clin Immunol; 2022 Sep; 150(3):709-713. PubMed ID: 35469843
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States.
Huang KP; Mullangi S; Guo Y; Qureshi AA
JAMA Dermatol; 2013 Jul; 149(7):789-94. PubMed ID: 23700152
[TBL] [Abstract][Full Text] [Related]
12. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea.
Bae JM; Lee JH; Yun JS; Han B; Han TY
J Am Acad Dermatol; 2017 May; 76(5):871-878. PubMed ID: 28238453
[TBL] [Abstract][Full Text] [Related]
13. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK.
Conrad N; Misra S; Verbakel JY; Verbeke G; Molenberghs G; Taylor PN; Mason J; Sattar N; McMurray JJV; McInnes IB; Khunti K; Cambridge G
Lancet; 2023 Jun; 401(10391):1878-1890. PubMed ID: 37156255
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of vitiligo, associated autoimmune diseases and audiological abnormalities: Ankara study of 80 patients in Turkey.
Akay BN; Bozkir M; Anadolu Y; Gullu S
J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1144-50. PubMed ID: 20202047
[TBL] [Abstract][Full Text] [Related]
15. Increased risk for type I (insulin-dependent) diabetes in relatives of patients with alopecia areata (AA).
Wang SJ; Shohat T; Vadheim C; Shellow W; Edwards J; Rotter JI
Am J Med Genet; 1994 Jul; 51(3):234-9. PubMed ID: 8074151
[TBL] [Abstract][Full Text] [Related]
16. Familial Risk of Sjögren's Syndrome and Co-aggregation of Autoimmune Diseases in Affected Families: A Nationwide Population Study.
Kuo CF; Grainge MJ; Valdes AM; See LC; Luo SF; Yu KH; Zhang W; Doherty M
Arthritis Rheumatol; 2015 Jul; 67(7):1904-12. PubMed ID: 25940005
[TBL] [Abstract][Full Text] [Related]
17. Vitiligo and associated autoimmune disease: retrospective review of 300 patients.
Sawicki J; Siddha S; Rosen C
J Cutan Med Surg; 2012; 16(4):261-6. PubMed ID: 22784519
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of thyroid dysfunction in systemic lupus erythematosus.
Appenzeller S; Pallone AT; Natalin RA; Costallat LT
J Clin Rheumatol; 2009 Apr; 15(3):117-9. PubMed ID: 19300286
[TBL] [Abstract][Full Text] [Related]
19. Alopecia areata and overt thyroid diseases: A nationwide population-based study.
Han TY; Lee JH; Noh TK; Choi MW; Yun JS; Lee KH; Bae JM
J Dermatol; 2018 Dec; 45(12):1411-1417. PubMed ID: 30222206
[TBL] [Abstract][Full Text] [Related]
20. In children with autoimmune thyroid diseases the association with Down syndrome can modify the clustering of extra-thyroidal autoimmune disorders.
Aversa T; Valenzise M; Corrias A; Salerno M; Iughetti L; Tessaris D; Capalbo D; Predieri B; De Luca F; Wasniewska M
J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1041-6. PubMed ID: 27442363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
